Shopping Cart 0
Cart Subtotal
USD 0

Sernova Corp (SVA) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375

Details

Sernova Corp (SVA)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases. The company develops Cell Pouch System, an implantable medical device, which offers a natural organ-like environment for the long term survival and function of insulin producing islets for the treatment of diabetes. Sernova uses proprietary local immune protection technologies that protect therapeutic cells within the Cell Pouch from the attack of immune system. The company's product portfolio addresses metabolic diseases such as insulin dependent diabetes, thyroid problems and blood disorders such as hemophilia A; and other neurological ailments. Sernova is headquartered in London, Ontario, Canada.

Sernova Corp Key Recent Developments

Oct 24,2019: Sernova announces Biotech Veteran as new Chief Financial Officer

Sep 17,2019: Sernova renews Frontier Flex for Canadian investor relations and marketing

May 21,2019: Sernova names Ms. Deborah Brown to its Board of Directors

Jan 30,2019: Sernova names Dr. David Lillicrap, M.D. to its scientific advisory board

Jan 28,2019: Sernova to participate on diabetes panel and present at NobleConXV, 15th Annual Investor Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Sernova Corp-Key Facts

Sernova Corp-Key Employees

Sernova Corp-Key Employee Biographies

Sernova Corp-Major Products and Services

Sernova Corp-History

Sernova Corp-Locations And Subsidiaries

Head Office

Section 2-Company Analysis

Company Overview

Sernova Corp-Business Description

Sernova Corp-Corporate Strategy

Sernova Corp-SWOT Analysis

SWOT Analysis-Overview

Sernova Corp-Strengths

Sernova Corp-Weaknesses

Sernova Corp-Opportunities

Sernova Corp-Threats

Sernova Corp-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Sernova Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Sernova Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

Sernova Corp, Recent Deals Summary

Section 5-Company's Recent Developments

Oct 24, 2019: Sernova announces Biotech Veteran as new Chief Financial Officer

Sep 17, 2019: Sernova renews Frontier Flex for Canadian investor relations and marketing

May 21, 2019: Sernova names Ms. Deborah Brown to its Board of Directors

Jan 30, 2019: Sernova names Dr. David Lillicrap, M.D. to its scientific advisory board

Jan 28, 2019: Sernova to participate on diabetes panel and present at NobleConXV, 15th Annual Investor Conference

Jul 23, 2018: Sernova Completes Oversubscribed Private Placement of USD 2,754,000

Jun 26, 2018: Sernova Announces USD 2 Million Private Placement Financing

May 04, 2018: Sernova Announces Results of 2018 Annual General Meeting of Shareholders and New Chief Financial Officer

Feb 14, 2018: The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor Day

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Sernova Corp, Performance Chart (2014-2018)

Sernova Corp, Ratio Charts

Sernova Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Sernova Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Sernova Corp, Key Facts

Sernova Corp, Key Employees

Sernova Corp, Key Employee Biographies

Sernova Corp, Major Products and Services

Sernova Corp, History

Sernova Corp, Key Competitors

Sernova Corp, Ratios based on current share price

Sernova Corp, Annual Ratios

Sernova Corp, Interim Ratios

Sernova Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Sernova Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

Sernova Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Sernova Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Generex Biotechnology Corp

Diamyd Medical AB

ConjuChem LLC

AstraZeneca Plc

Alnara Pharmaceuticals Inc

Sernova Corp (SVA)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases. The company develops Cell Pouch System, an implantable medical device, which offers a natural organ-like environment for the long term survival and function of insulin producing islets for the treatment of diabetes. Sernova uses proprietary local immune protection technologies that protect therapeutic cells within the Cell Pouch from the attack of immune system. The company's product portfolio addresses metabolic diseases such as insulin dependent diabetes, thyroid problems and blood disorders such as hemophilia A; and other neurological ailments. Sernova is headquartered in London, Ontario, Canada.

Sernova Corp Key Recent Developments

Oct 24,2019: Sernova announces Biotech Veteran as new Chief Financial Officer

Sep 17,2019: Sernova renews Frontier Flex for Canadian investor relations and marketing

May 21,2019: Sernova names Ms. Deborah Brown to its Board of Directors

Jan 30,2019: Sernova names Dr. David Lillicrap, M.D. to its scientific advisory board

Jan 28,2019: Sernova to participate on diabetes panel and present at NobleConXV, 15th Annual Investor Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Sernova Corp-Key Facts

Sernova Corp-Key Employees

Sernova Corp-Key Employee Biographies

Sernova Corp-Major Products and Services

Sernova Corp-History

Sernova Corp-Locations And Subsidiaries

Head Office

Section 2-Company Analysis

Company Overview

Sernova Corp-Business Description

Sernova Corp-Corporate Strategy

Sernova Corp-SWOT Analysis

SWOT Analysis-Overview

Sernova Corp-Strengths

Sernova Corp-Weaknesses

Sernova Corp-Opportunities

Sernova Corp-Threats

Sernova Corp-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Sernova Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Sernova Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

Sernova Corp, Recent Deals Summary

Section 5-Company's Recent Developments

Oct 24, 2019: Sernova announces Biotech Veteran as new Chief Financial Officer

Sep 17, 2019: Sernova renews Frontier Flex for Canadian investor relations and marketing

May 21, 2019: Sernova names Ms. Deborah Brown to its Board of Directors

Jan 30, 2019: Sernova names Dr. David Lillicrap, M.D. to its scientific advisory board

Jan 28, 2019: Sernova to participate on diabetes panel and present at NobleConXV, 15th Annual Investor Conference

Jul 23, 2018: Sernova Completes Oversubscribed Private Placement of USD 2,754,000

Jun 26, 2018: Sernova Announces USD 2 Million Private Placement Financing

May 04, 2018: Sernova Announces Results of 2018 Annual General Meeting of Shareholders and New Chief Financial Officer

Feb 14, 2018: The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor Day

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Sernova Corp, Performance Chart (2014-2018)

Sernova Corp, Ratio Charts

Sernova Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Sernova Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Sernova Corp, Key Facts

Sernova Corp, Key Employees

Sernova Corp, Key Employee Biographies

Sernova Corp, Major Products and Services

Sernova Corp, History

Sernova Corp, Key Competitors

Sernova Corp, Ratios based on current share price

Sernova Corp, Annual Ratios

Sernova Corp, Interim Ratios

Sernova Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Sernova Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

Sernova Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Sernova Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Generex Biotechnology Corp

Diamyd Medical AB

ConjuChem LLC

AstraZeneca Plc

Alnara Pharmaceuticals Inc